Skip to main content
. 2026 Jul 7;18(7):830. doi: 10.3390/pharmaceutics18070830
API Active pharmaceutical ingredient
AUC Area under the curve
Cmax Maximum concentration
CQA Critical quality attribute
CQAs Critical quality attributes
CsA Cyclosporine A
DED Dry eye disease
DLP Digital light processing
FDA Food and Drug Administration
FT-IR Fourier-transform infrared spectroscopy
FTN Fluorescent tracing nanoparticles
GRADE Grading of Recommendations Assessment, Development and Evaluation
HAMA Methacrylate-modified hyaluronic acid
HBC Hydroxybutyl chitosan
HPLC High-performance liquid chromatography
ICH International Council for Harmonisation
IOP Intraocular pressure
IVIS In vivo imaging system
LAP Lithium phenyl-2,4,6-trimethylbenzoylphosphinate
L-PPDS Latanoprost punctal plug delivery system
N-PPDS Nepafenac punctal plug delivery system
NMP N-methyl-2-pyrrolidone
PEG Polyethylene glycol
PEG 400 Polyethylene glycol 400
PEGDA Polyethylene glycol diacrylate
PPDS Punctal plug delivery system
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PVP Polyvinylpyrrolidone
QbD Quality by design
QTPP Target product quality profile
SEM Scanning electron microscopy
SFMA Silk fibroin methacrylate
TEM Transmission electron microscopy
UV Ultraviolet